VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G Report for Soleno Therapeutics Inc Common Stock (SLNO)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
SLNO
Shares outstanding
53,165,701 shares
Disclosed Ownership
2,807,149 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
31 Oct 2025, 11:31:25 UTC
Date of event
30 Sep 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 5.3% 2,807,149 0 323,949 Ashley Grim Head of Global Fund Administration